Company Will
Ring the Bell to Open the Market Monday, July 24
TSXV: ACB
VANCOUVER, July 21, 2017 /CNW/ - Aurora Cannabis Inc. (the
"Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today
that common shares of the Company will commence trading on Toronto
Stock Exchange (the "TSX") effective Monday
July 24. Common shares will continue to trade under the
symbol "ACB". In conjunction with listing on TSX, the common shares
have been voluntarily delisted from TSX Venture Exchange, effective
close of trading today, Friday, July 21,
2017. Aurora will "ring the bell" to open TSX on
Monday, July 24, 2017.
"Aurora's graduation to TSX reflects the remarkable commercial
and operational progress we have made since listing on TSX Venture
Exchange late last year," said Terry
Booth, CEO. "We are achieving record yields at our
Mountain View County production facility, progressing rapidly with
the construction of our 100,000+ kg per annum Aurora Sky facility
at Edmonton International Airport,
and are executing consistently on our national and international
expansion strategy. The acquisition of our third production
facility, in Pointe-Claire, Québec
will further support our domestic growth. Our acquisition of
Pedanios, Germany's largest
medical cannabis distributor, and our strategic investment in
Australia's Cann Group, have
established Aurora as a global leader in the cannabis sector.
Aurora continues to drive innovation in the industry, as evidenced
by our research collaboration with and investment in Radient
Technologies, the launch and upgrades of our one-of-a-kind mobile
application, and the expansion of our same-day and next-day
delivery program. We expect that graduating to TSX will further
increase our shareholder audience, and represents another important
strategic step in enhancing shareholder value."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, and is currently
constructing a second 800,000 square foot production facility,
known as "Aurora Sky", at the Edmonton International Airport, and has
acquired, and is undertaking completion of, a third 40,000 square
foot production facility in Pointe-Claire, Quebec, on Montreal's West Island. In
addition, the company is the cornerstone investor with a 19.9%
stake in Cann Group Limited, the first Australian company licensed
to conduct research on and cultivate medical cannabis, as well as
owns Pedanios, a leading wholesale importer, exporter, and
distributor of medical cannabis in the European Union ("EU"), based
in Germany. Aurora's common shares now trade on TSX under the
symbol "ACB".
On behalf of the Board of
Directors,
AURORA CANNABIS
INC.
Terry Booth, CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor TSX Venture Exchange (nor its Regulation
Services Provider as that term is defined in the policies of TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Aurora Cannabis Inc.